Apeng Wang
Impact in
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology
- Organic Chemistry top 10%
- Synthesis and biological activity
- Quinazolinone synthesis and applications
- Synthesis and Biological Evaluation
Papers in
-
- Cancer therapeutics and mechanisms 14
- Phenothiazines and Benzothiazines Synthesis and Activities 12
-
- Tuberculosis Research and Epidemiology 10
- Co-authors
- Mingliang Liu (33 shared papers)Kai Lv (28 shared papers)Yu Lu (19 shared papers)Huiyuan Guo (9 shared papers)Chao Ma (9 shared papers)Yun Chai (4 shared papers)Hongjian Wang (7 shared papers)Aoyu Wang (7 shared papers)
- Journals
- European Journal of Medicinal Chemistry (14 papers)Chinese Chemical Letters (3 papers)ACS Medicinal Chemistry Letters (3 papers)Bioorganic & Medicinal Chemistry (3 papers)Tetrahedron (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Apeng Wang
40 papers receiving 560 citations
Peers
Comparison fields: 5 of 59
- Infectious Diseases 214
- Organic Chemistry 280
- Molecular Biology 333
- Hepatology 28
- Molecular Medicine 19
Countries citing papers authored by Apeng Wang
This map shows the geographic impact of Apeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Apeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Apeng Wang more than expected).
Fields of papers citing papers by Apeng Wang
This network shows the impact of papers produced by Apeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Apeng Wang. The network helps show where Apeng Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Apeng Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 55 | |
| 2 | 2017 | 40 | |
| 3 | 2018 | 36 | |
| 4 | 2019 | 33 | |
| 5 | 2018 | 31 | |
| 6 | 2018 | 30 | |
| 7 | 2018 | 29 | |
| 8 | 2018 | 25 | |
| 9 | 2019 | 24 | |
| 10 | 2021 | 21 | |
| 11 | 2019 | 18 | |
| 12 | 2018 | 16 | |
| 13 | 2016 | 16 | |
| 14 | 2020 | 15 | |
| 15 | 2019 | 15 | |
| 16 | 2019 | 14 | |
| 17 | 2019 | 13 | |
| 18 | 2018 | 13 | |
| 19 | 2021 | 11 | |
| 20 | 2023 | 11 |
About Apeng Wang
Apeng Wang is a scholar working on Molecular Biology, Infectious Diseases, Organic Chemistry, Epidemiology and Hepatology, having authored 40 papers that have together received 570 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (14 papers), Phenothiazines and Benzothiazines Synthesis and Activities (12 papers), Tuberculosis Research and Epidemiology (10 papers), Quinazolinone synthesis and applications (6 papers), Hepatitis B Virus Studies (5 papers), Hepatitis C virus research (5 papers), Carbohydrate Chemistry and Synthesis (5 papers) and Synthesis and Biological Evaluation (4 papers). The work is most often cited by research in Infectious Diseases (214 citations), Organic Chemistry (280 citations), Molecular Biology (333 citations), Hepatology (28 citations) and Molecular Medicine (19 citations). Apeng Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Mingliang Liu, Kai Lv, Yu Lu, Huiyuan Guo, Chao Ma, Yun Chai, Hongjian Wang, Aoyu Wang, Bin Wang and Shuo Wu. Their work appears in journals such as European Journal of Medicinal Chemistry, Chinese Chemical Letters, ACS Medicinal Chemistry Letters, Bioorganic & Medicinal Chemistry and Tetrahedron.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.